| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/06/2013 | WO2013079973A1 Antibodies against hgf - receptor and uses |
| 06/06/2013 | WO2013079953A1 Fertile transgenic animals useful for producing antibodies bearing human variable regions |
| 06/06/2013 | WO2013079945A1 Method to improve the immune function of t cells |
| 06/06/2013 | WO2013079713A1 Improving trabeculectomy outcome |
| 06/06/2013 | WO2013079174A1 Anti-pd-l1 antibodies and uses thereof |
| 06/06/2013 | WO2013078511A1 Anti-npy and pyy antibodies and uses thereof |
| 06/06/2013 | WO2013051878A3 Antibody specifically binding to epitope in sema domain of c-met |
| 06/06/2013 | WO2013050383A3 In vitro method to determine the risk of a pregnant woman of carrying a fetus with fetal aneuploidy |
| 06/06/2013 | WO2013024100A3 Methods for diagnosing and treating medical conditions associated with oxidative stress |
| 06/06/2013 | WO2012139106A3 Herpes simplex virus |
| 06/06/2013 | US20130144042 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/06/2013 | US20130144041 Homogeneous antibody populations |
| 06/06/2013 | US20130144040 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 06/06/2013 | US20130143827 Tanaproget derivatives, metabolites, and uses thereof |
| 06/06/2013 | US20130143316 Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer |
| 06/06/2013 | US20130143294 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 06/06/2013 | US20130143269 KIR-Binding Agents and Methods of Use Thereof |
| 06/06/2013 | US20130143266 Anti-ephrinb2 antibodies and methods using same |
| 06/06/2013 | US20130143250 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 06/06/2013 | US20130143245 Recombinant protein capable of binding specifically and quickly to troponin i derived from human myocardium |
| 06/06/2013 | US20130143242 Monoclonal antibody against group 2 allergen of dermatophagoides pteronyssiuns, hybridoma cell line producing thereof, strip, kit and method using said monoclonal antibody for dust mite assay |
| 06/06/2013 | US20130143237 Compositions and methods for prostate cancer analysis |
| 06/06/2013 | US20130143231 MST1/STK4 PHOSPHO-THREONINE 120 (pMST-T120) ANTIBODY |
| 06/06/2013 | US20130142813 Antibody binding to lysophosphatidylglucoside, and composition comprising the same |
| 06/06/2013 | US20130142812 Antibody and use thereof |
| 06/06/2013 | US20130142811 Antibody Modulating The Differentiation And Function Of Dendritic Cells Via Binding Intercellular Adhesion Molecule-1 And Use Thereof |
| 06/06/2013 | US20130142806 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |
| 06/06/2013 | US20130142804 Antibodies That Are Capable of Specifically Binding Tissue Factor Pathway Inhibitor |
| 06/06/2013 | US20130142802 Antibody molecules to oncogenic isoforms of fibroblast growth factor receptor-2 and uses thereof |
| 06/06/2013 | US20130142800 Mycobacterial Antigen Composition |
| 06/06/2013 | US20130142799 Angiopoietin-2 Specific Binding Agents |
| 06/06/2013 | US20130142798 Methods for diagnosing cancer and decreasing metastasis by cancer cells |
| 06/06/2013 | US20130142797 Method of treating virus-induced cancer |
| 06/06/2013 | US20130142795 Fusion protein of exendin-4 and its analog, preparation method and use thereof |
| 06/06/2013 | US20130142793 Binding domain-immunoglobulin fusion proteins |
| 06/06/2013 | US20130142792 RAGE Fusion Protein Compositions And Methods Of Use |
| 06/06/2013 | US20130142789 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodies |
| 06/06/2013 | US20130142788 Humanised antigen binding proteins to myostatin6 |
| 06/06/2013 | US20130142786 Humanized and chimeric monoclonal antibodies to cd47 |
| 06/06/2013 | US20130142783 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 06/06/2013 | US20130142780 Method for isolation of soluble polypeptides |
| 06/06/2013 | CA2857666A1 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| 06/06/2013 | CA2857645A1 Assays, antibodies, immunogens and compositions related to 5-fu |
| 06/06/2013 | CA2857569A1 Fertile transgenic animals useful for producing antibodies bearing human variable regions |
| 06/06/2013 | CA2857298A1 Vectors and host cells comprising a modified sv40 promoter for protein expression |
| 06/06/2013 | CA2857159A1 Drug containing carrier into cell for forming immune complex |
| 06/06/2013 | CA2857019A1 Novel enhanced selectin antagonists |
| 06/06/2013 | CA2856895A1 Anti-pd-l1 antibodies and uses thereof |
| 06/05/2013 | EP2600151A1 Reagent and reagent kit for measurement of fdp, and measurement method |
| 06/05/2013 | EP2599865A1 Anti-fdp monoclonal antibody, fdp measurement reagent and reagent kit using same, and fdp measurement method |
| 06/05/2013 | EP2599793A1 Anti-phospho-akt antibodies |
| 06/05/2013 | EP2599792A1 Antibody directed against PcrV |
| 06/05/2013 | EP2599791A1 Potent, stable and non-immunosuppressive anti-CD4 antibodies |
| 06/05/2013 | EP2599504A2 Use of conjugates of fsh receptor ligands and antitumour agents for therapy of cancer |
| 06/05/2013 | EP2599503A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 06/05/2013 | EP2598882A2 Safe and functional humanized antibodies |
| 06/05/2013 | EP2598534A1 Antibodies relating to pivka-ii and uses thereof |
| 06/05/2013 | EP2598533A2 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions |
| 06/05/2013 | EP2598532A1 Epitopes of the human pdgf receptor able to bind human auto-antibodies, antibodies and uses thereof |
| 06/05/2013 | EP2598531A1 Methods and compositions for liver cancer therapy |
| 06/05/2013 | EP2598530A2 Antibodies with modified isoelectric points |
| 06/05/2013 | EP2598529A2 Fibronectin cradle molecules and libraries thereof |
| 06/05/2013 | EP2598516A2 Process for purifying proteins |
| 06/05/2013 | EP2598168A2 Combination therapy for treating cancer comprising an igf-1r inhibitor and an akt inhibitor |
| 06/05/2013 | EP2598167A1 Stabilized aqueous antibody compositions |
| 06/05/2013 | EP2598164A2 Peripheral blood sparc antibodies and uses thereof |
| 06/05/2013 | EP2597945A2 Transgenic animals and methods of use |
| 06/05/2013 | CN103140758A Immunochromatography devices, methods and kits |
| 06/05/2013 | CN103140501A Cancer therapy using cldn6 target-directed antibodies in vivo |
| 06/05/2013 | CN103140500A Anti-addl monoclonal antibody and uses thereof |
| 06/05/2013 | CN103131771A C1q gene and application of coding protein of C1q gene |
| 06/05/2013 | CN103130897A Atrazine single-chain antibody screening method and purpose thereof |
| 06/05/2013 | CN103130896A Monoclonal antibody for resisting cell surface ectopic expression, and preparation method and application thereof |
| 06/05/2013 | CN103130895A Specific binding members against synaptophysin |
| 06/05/2013 | CN103130894A Recombinant single-chain antibody G5-4ScFv of anti-human gamma delta T cell receptor (TCR) monoclonal antibody and encoding gene and application thereof |
| 06/05/2013 | CN103130893A Diethylstilbestrol single-chain antibody screening method and purpose of diethylstilbestrol single-chain antibody |
| 06/05/2013 | CN103130892A Aflatoxin recombination single-chain antibody 2G7, encoding gene and application thereof |
| 06/05/2013 | CN103130891A Antibody and encoding gene of mycobacterium tuberculosis Acr protein and application thereof |
| 06/05/2013 | CN103130890A Human papillomavirus (HPV) 16E7 monoclonal antibody and relevant hybridoma cell strain and application thereof |
| 06/05/2013 | CN103127502A Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 06/05/2013 | CN102477096B Human creatine kinase single-chain antibody with molecular chaperone function |
| 06/05/2013 | CN102399288B Immunoglobulin Fc (fragment crystalline) targeted single-domain heavy-chain antibody |
| 06/05/2013 | CN102372773B Human bladder cancer tumor marker, antibody thereof and application thereof |
| 06/05/2013 | CN102321172B Method for separation and preparation of livestock serum immunoglobulin powder with ferric salt |
| 06/05/2013 | CN102199208B Universal medicine delivery system and preparation method thereof |
| 06/05/2013 | CN102180950B Human-derived voltage-gated potassium channel 1.3 immunogenic peptide fragment and application thereof |
| 06/05/2013 | CN101975856B Preparation method of fluorescence antibody for detecting Newcastle disease virus and solid-phase immunofluorescence detection assay kit |
| 06/05/2013 | CN101903401B Stability testing of antibodies |
| 06/05/2013 | CN101875689B New gene for rice zinc-finger protein transcription factor and application thereof in drought resistance and salt tolerance |
| 06/05/2013 | CN101809162B Anti-glypican-3 antibody having improved kinetics in plasma |
| 06/05/2013 | CN101754978B Antigen associated with lung cancer and lymphoma |
| 06/05/2013 | CN101326197B Human monoclonal antibodies to O8E |
| 06/05/2013 | CN101115771B 人类抗体和蛋白质 Human antibodies and proteins |
| 06/05/2013 | CN101056979B Anti-histone H1 monoclonal antibody and hybridoma capable of producing the same |
| 06/04/2013 | USRE44266 Expression of eukaryotic polypeptides in chloroplasts |
| 06/04/2013 | US8455629 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 06/04/2013 | US8455627 Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa |
| 06/04/2013 | US8455626 Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| 06/04/2013 | US8455625 Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12 |
| 06/04/2013 | US8455623 Compositions and methods for diagnosing and treating cancer |